Slc26a2 Related Skeletal Dysplasia Cn379209
A genetic disorder affecting cartilage and bone development. It typically appears in infancy or early childhood. Treatment includes supportive care, physical therapy, and orthopedic management as needed.
Key facts at a glance
- ICD-10
- Q79.9
- ICD-11
- LA00.0
- Body system
- musculoskeletal
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Joint contractures
(musculoskeletal)Joint pain or stiffness
(musculoskeletal)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Scoliosis
(musculoskeletal)Hearing loss
(musculoskeletal)Cleft palate
(musculoskeletal)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Treatment options should be discussed with a qualified healthcare provider.
Developmental Physical Therapy
Early intervention therapy focusing on gross motor development, balance training, and functional mobility skills.
Skeletal Deformity Correction
Corrective orthopedic surgeries for limb length discrepancies, joint malformations, or spinal curvature.
Additional treatment options
Respiratory Function Assessment
Pulmonary evaluation to monitor for restrictive lung disease that may accompany severe skeletal dysplasia.
monitoringJoint Injection Therapy
Intra-articular corticosteroid or hyaluronic acid injections for symptomatic joint pain and inflammation.
procedureOccupational Therapy Support
ADL training, adaptive techniques, and environmental modifications to maximize functional independence.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Slc26a2 Related Skeletal Dysplasia Cn379209?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Rossi A, Superti-Furga A, Bonafé L. Clinical practice guidelines for SLC26A2-related skeletal dysplasias. Orphanet J Rare Dis. 2022.
Karniski LP, Dwyer E. The SLC26A2 transporter and sulfate transport in skeletal development. Mol Genet Metab. 2020.
Hästbacka J, Newton CR, de la Chapelle A. Genotype-phenotype correlation in SLC26A2 mutations: a multicenter study. J Bone Miner Res. 2019.
Mäkitie O, Bonafé L, Baldo F. Diagnostic approach to SLC26A2-related skeletal dysplasia: clinical and radiological features. Eur J Med Genet. 2021.
Medication Comparisons
Compare medications used to treat Slc26a2 Related Skeletal Dysplasia Cn379209. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy